7

rezultat(a)

Riječ(i)
Vrsta publikacije
Područje politike
Ključna riječ
Datum

Javno zdravstvo

01-02-2018

U Ugovoru iz Lisabona daje se veća važnost zdravstvenoj politici te se navodi da se „u utvrđivanju i provedbi svih politika i aktivnosti Unije osigurava visok stupanj zaštite zdravlja ljudi”. Taj se cilj može ostvariti podrškom Unije državama članicama i poticanjem suradnje. Glavnu odgovornost za zaštitu zdravlja, a posebno za zdravstvene sustave, i dalje imaju države članice. No Europska unija ima važnu ulogu u poboljšanju javnog zdravlja, sprečavanju i upravljanju bolesti, ublažavanju izvora opasnosti ...

U Ugovoru iz Lisabona daje se veća važnost zdravstvenoj politici te se navodi da se „u utvrđivanju i provedbi svih politika i aktivnosti Unije osigurava visok stupanj zaštite zdravlja ljudi”. Taj se cilj može ostvariti podrškom Unije državama članicama i poticanjem suradnje. Glavnu odgovornost za zaštitu zdravlja, a posebno za zdravstvene sustave, i dalje imaju države članice. No Europska unija ima važnu ulogu u poboljšanju javnog zdravlja, sprečavanju i upravljanju bolesti, ublažavanju izvora opasnosti za ljudsko zdravlje i usklađivanju zdravstvenih strategija među državama članicama. EU je uspješno proveo sveobuhvatnu politiku preko svoje zdravstvene strategije „Zdravlje za rast” i povezanog akcijskog programa (2014. – 2020.) te korpusa sekundarnog zakonodavstva. Sadašnje institucionalno ustrojstvo za potporu provedbi obuhvaća Glavnu upravu Europske komisije za zdravlje i sigurnost hrane (DG SANTE) i specijalizirane agencije, osobito Europski centar za sprečavanje i kontrolu bolesti (ECDC) i Europsku agenciju za lijekove (EMA).

Lijekovi i medicinski proizvodi

01-02-2018

Lijekovi i medicinski proizvodi podliježu pravilima jedinstvenoga tržišta te je za njihovo odobrenje nadležna Europska unija, koja izrađuje procjene i provodi nadzor. Radi zaštite javnoga zdravlja, Europska agencija za lijekove (EMA) u okviru centraliziranog postupka i/ili nacionalne agencije na decentraliziran način odobravaju nove farmaceutske proizvode za ljudsku uporabu prije nego što se oni stave na tržište. Medicinski proizvodi iziskuju detaljni regulatorni okvir za pristup tržištu preko organizacija ...

Lijekovi i medicinski proizvodi podliježu pravilima jedinstvenoga tržišta te je za njihovo odobrenje nadležna Europska unija, koja izrađuje procjene i provodi nadzor. Radi zaštite javnoga zdravlja, Europska agencija za lijekove (EMA) u okviru centraliziranog postupka i/ili nacionalne agencije na decentraliziran način odobravaju nove farmaceutske proizvode za ljudsku uporabu prije nego što se oni stave na tržište. Medicinski proizvodi iziskuju detaljni regulatorni okvir za pristup tržištu preko organizacija privatnog sektora koja se zovu prijavljena tijela. Trenutačno se provode revizije i novi će zakonodavni postupak stupiti na snagu 2017.

Commitments Made at the Hearings of the Commissioners-Designate, Juncker Commission (November 2014 - October 2019)

14-11-2014

This compilation of briefings presents the most salient points and essential commitments made by the commissioners-designate during the hearings held in September/October 2014 before the parliamentary committees. These commitments concern the main on-going legislative procedures, the preparation of future legislative proposals as well as the scrutiny of the implementation of existing legislation. They also touch upon the crucial issue of inter-institutional cooperation.

This compilation of briefings presents the most salient points and essential commitments made by the commissioners-designate during the hearings held in September/October 2014 before the parliamentary committees. These commitments concern the main on-going legislative procedures, the preparation of future legislative proposals as well as the scrutiny of the implementation of existing legislation. They also touch upon the crucial issue of inter-institutional cooperation.

Commitments Made at the Hearing of Vytenis Andriukaitis - Commissioner-Designate

04-11-2014

Briefing summarises commitments made at the hearing of Vytenis Andriukaitis Commissioner designate for Health & Food Safety.

Briefing summarises commitments made at the hearing of Vytenis Andriukaitis Commissioner designate for Health & Food Safety.

Commitments Made at the Hearing of Miguel Arias Cañete - Commissioner-Designate

04-11-2014

Briefing summarises commitments made at the hearing Miguel Arias Cañete Commissioner designate for Climate Action & Energy.

Briefing summarises commitments made at the hearing Miguel Arias Cañete Commissioner designate for Climate Action & Energy.

Disease Mongering (Pseudo-Disease Promotion)

15-11-2012

Disease mongering is the promotion of pseudo-diseases by the pharmaceutical industry aiming at economic benefit. Medical equipment manufacturers, insurance companies, doctors or patient groups may also use it for monetary gain or influence. It has increased in parallel with society's 'medicalisation' and the growth of the pharmaceutical complex. Due to massive investments in marketing and lobbying, ample use of internet and media, and the emergence of new markets, it is becoming a matter of concern ...

Disease mongering is the promotion of pseudo-diseases by the pharmaceutical industry aiming at economic benefit. Medical equipment manufacturers, insurance companies, doctors or patient groups may also use it for monetary gain or influence. It has increased in parallel with society's 'medicalisation' and the growth of the pharmaceutical complex. Due to massive investments in marketing and lobbying, ample use of internet and media, and the emergence of new markets, it is becoming a matter of concern, and policy makers should be aware of its perils and consequences.

Workshop Report on 'Health in All Policies (HiAP)' - Brussels, 25 May 2011

15-08-2011

For many years the health consequences of new legislation have been taken into account during the policy formulation process in areas such as agriculture, environment, food and others. The inclusion of Health in All Policies is now enshrined in the Lisbon Treaty (Art. 168). The aim of the workshop was to present an update on how the system is actually functioning within the different Commission services. Several DGs representatives, led by DG SANCO, made contributions. The case of The Netherlands ...

For many years the health consequences of new legislation have been taken into account during the policy formulation process in areas such as agriculture, environment, food and others. The inclusion of Health in All Policies is now enshrined in the Lisbon Treaty (Art. 168). The aim of the workshop was to present an update on how the system is actually functioning within the different Commission services. Several DGs representatives, led by DG SANCO, made contributions. The case of The Netherlands as an example of how it works in a Member State was also presented.

Buduća događanja

Partneri

Ostanite povezani

email update imageSustav primanja novosti elektroničkom poštom

Zahvaljujući sustavu slanja obavijesti e-poštom koji izravno šalje najnovije informacije na vašu adresu elektroničke pošte možete pratiti novosti o svim osobama i događajima u vezi s Parlamentom. To uključuje novosti u vezi sa zastupnicima, usluge informiranja ili rubriku Think Tank.

Sustav je dostupan na bilo kojoj stranici internetskog portala Parlamenta. Kako biste se predbilježili i počeli dobivati obavijesti iz rubrike Think Tank, dovoljno je upisati svoju adresu e-pošte, odabrati temu koja vas zanima, naznačiti učestalost kojom ih želite dobivati (svakodnevno, tjedno ili mjesečno) i potvrditi registraciju pritiskom na poveznicu koju ćete dobiti na adresu e-pošte.

RSS imageIzvori vijesti

Ne propustite informacije ili novosti s internetskog portala Europskog parlamenta zahvaljujući RSS prijenosu.

Odaberite dolje naznačenu poveznicu kako biste konfigurirali RSS prijenos.